Filed: 5/6/2026ACC: 0001754960-26-000359
📋 What this filing means
BML CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 16 equity positions with a total reported market value of $155.77M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
16
Positions
$155.77M
Total AUM (reported)
37.84M
Total Shares
Allocation by class
COM$116.92M75.1%
COM NEW$28.74M18.5%
CL A$8.71M5.6%
SHS$1.07M0.7%
PUT$329.1K0.2%
Portfolio Concentration
Top 3$102.18M65.6%
4–10$44.27M28.4%
11–25$9.32M6.0%
Top 3 weight
65.6%
Top 10 weight
94.0%
Voting Authority Distribution
Total shares with voting rights: 37.84M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
37.84M
shares
% of voting shares100.0%
Investment Discretion (by position count)
Sole16
Shared0
Other0
Dominant voting typeNone · 100.0% of voting shares
Institutional Holdings16
Rows:
ACLARIS THERAPEUTICS INC
SOLEShares14.25M
TypeSH
Market value$53.44M
34.31%
Sole
0.00
Shared
0.00
None
14.25M
ATEA PHARMACEUTICALS INC
SOLEShares7.06M
TypeSH
Market value$37.98M
24.38%
Sole
0.00
Shared
0.00
None
7.06M
ORAMED PHARMACEUTICALS INC
SOLEShares3.17M
TypeSH
Market value$10.77M
6.91%
Sole
0.00
Shared
0.00
None
3.17M
TILLYS INC
SOLEShares2.15M
TypeSH
Market value$8.71M
5.59%
Sole
0.00
Shared
0.00
None
2.15M
OUTSET MED INC
SOLEShares1.90M
TypeSH
Market value$7.30M
4.69%
Sole
0.00
Shared
0.00
None
1.90M
PMV PHARMACEUTICALS INC
SOLEShares5.32M
TypeSH
Market value$6.60M
4.24%
Sole
0.00
Shared
0.00
None
5.32M
CARMAX INC
SOLEShares155K
TypeSH
Market value$6.44M
4.14%
Sole
0.00
Shared
0.00
None
155K
KEZAR LIFE SCIENCES INC
SOLEShares720.79K
TypeSH
Market value$5.35M
3.43%
Sole
0.00
Shared
0.00
None
720.79K
INSTIL BIO INC
SOLEShares645.60K
TypeSH
Market value$5.32M
3.42%
Sole
0.00
Shared
0.00
None
645.60K
TARGET CORP
SOLEShares37.50K
TypeSH
Market value$4.54M
2.92%
Sole
0.00
Shared
0.00
None
37.50K
KRAFT HEINZ CO
SOLEShares125K
TypeSH
Market value$2.81M
1.80%
Sole
0.00
Shared
0.00
None
125K
JANUX THERAPEUTICS INC
SOLEShares154.96K
TypeSH
Market value$2.15M
1.38%
Sole
0.00
Shared
0.00
None
154.96K
PLIANT THERAPEUTICS INC
SOLEShares1.55M
TypeSH
Market value$1.95M
1.25%
Sole
0.00
Shared
0.00
None
1.55M
CONNECT BIOPHARMA HLDGS LTD
SOLEShares408.89K
TypeSH
Market value$1.07M
0.69%
Sole
0.00
Shared
0.00
None
408.89K
IMAGENEBIO INC
SOLEShares200.73K
TypeSH
Market value$1.00M
0.64%
Sole
0.00
Shared
0.00
None
200.73K
WALMART INC
SOLEShares335.00
TypeSH
Market value$329.1K
0.21%
Sole
0.00
Shared
0.00
None
335.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ACLARIS THERAPEUTICS INCSOLE | COM | 14.25M | SH | $53.44M 34.31% | 0.00 | 0.00 | 14.25M |
ATEA PHARMACEUTICALS INCSOLE | COM | 7.06M | SH | $37.98M 24.38% | 0.00 | 0.00 | 7.06M |
ORAMED PHARMACEUTICALS INCSOLE | COM NEW | 3.17M | SH | $10.77M 6.91% | 0.00 | 0.00 | 3.17M |
TILLYS INCSOLE | CL A | 2.15M | SH | $8.71M 5.59% | 0.00 | 0.00 | 2.15M |
OUTSET MED INCSOLE | COM NEW | 1.90M | SH | $7.30M 4.69% | 0.00 | 0.00 | 1.90M |
PMV PHARMACEUTICALS INCSOLE | COM | 5.32M | SH | $6.60M 4.24% | 0.00 | 0.00 | 5.32M |
CARMAX INCSOLE | COM | 155K | SH | $6.44M 4.14% | 0.00 | 0.00 | 155K |
KEZAR LIFE SCIENCES INCSOLE | COM NEW | 720.79K | SH | $5.35M 3.43% | 0.00 | 0.00 | 720.79K |
INSTIL BIO INCSOLE | COM NEW | 645.60K | SH | $5.32M 3.42% | 0.00 | 0.00 | 645.60K |
TARGET CORPSOLE | COM | 37.50K | SH | $4.54M 2.92% | 0.00 | 0.00 | 37.50K |
KRAFT HEINZ COSOLE | COM | 125K | SH | $2.81M 1.80% | 0.00 | 0.00 | 125K |
JANUX THERAPEUTICS INCSOLE | COM | 154.96K | SH | $2.15M 1.38% | 0.00 | 0.00 | 154.96K |
PLIANT THERAPEUTICS INCSOLE | COM | 1.55M | SH | $1.95M 1.25% | 0.00 | 0.00 | 1.55M |
CONNECT BIOPHARMA HLDGS LTDSOLE | SHS | 408.89K | SH | $1.07M 0.69% | 0.00 | 0.00 | 408.89K |
IMAGENEBIO INCSOLE | COM | 200.73K | SH | $1.00M 0.64% | 0.00 | 0.00 | 200.73K |
WALMART INCSOLE | PUT | 335.00 | SH | $329.1K 0.21% | 0.00 | 0.00 | 335.00 |